Cancer

CMS Grants Transitional Pass-Through (TPT) Payment for Ambu’s aScope 5 Broncho HD Single-Use Bronchoscope

Ambu’s fifth-generation single-use bronchoscope becomes the first and only bronchoscope to be granted incremental payment by CMS, facilitating Medicare beneficiary…

12 months ago

CMS Grants Transitional Pass-Through (TPT) Payment for Ambu’s aScope 5 Broncho HD Single-Use Bronchoscope

Ambu’s fifth-generation single-use bronchoscope becomes the first and only bronchoscope to be granted incremental payment by CMS, facilitating Medicare beneficiary…

12 months ago

HFS Research recognizes CitiusTech as a Market Leader in Horizons Report: Life Sciences Service Provider 2023

PRINCETON, N.J.--(BUSINESS WIRE)--#CitiusTech--CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, has been recognized as a Market Leader…

12 months ago

HFS Research recognizes CitiusTech as a Market Leader in Horizons Report: Life Sciences Service Provider 2023

PRINCETON, N.J.--(BUSINESS WIRE)--#CitiusTech--CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, has been recognized as a Market Leader…

12 months ago

How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure

HOUSTON, TX / ACCESSWIRE / December 6, 2023 / Every form of cancer is devastating, but the unfortunate reality is…

12 months ago

How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure

HOUSTON, TX / ACCESSWIRE / December 6, 2023 / Every form of cancer is devastating, but the unfortunate reality is…

12 months ago

Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus

PHILADELPHIA, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell…

12 months ago

Rezolut Announces Strategic Partnership with Women’s Health of Arizona

Leading Provider of White Label Mammography Expands Footprint in ArizonaPHOENIX, AZ / ACCESSWIRE / December 5, 2023 / Rezolut, LLC,…

12 months ago